Jeremy Nichols Obtains Citation Award For Work He Did As An MRC-PPU Postdoctoral Researcher
Jeremy Nichols who is now the Director of Signal Transduction & LRRK2 Biology Program at the Parkinson's Institute and Clinical Center in Sunnyvale California has just received a Citation award for his paper entitled '14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization' published in 2010 in the Biochemical Journal.
This paper was the most cited paper in the knowledge environment of Signalling for that year and currently has 46 citations. Jeremy trained in Dario Alessi's lab, as a postdoc from November 2006 - April 2010.
Jeremy stated 'This work was enabled by an environment of discovery at the MRCPPU, in a laboratory focused on disease signaling. All of the authors involved were able to make an impact in the LRRK2 field as is evidenced by this acknowledgement. In fact, detection of phosphorylation at Serines 910 and 935 as a measure of LRRK2 inhibition LRRK2 has enabled many drug discovery programs to continue and are windows into LRRK2 biology.'
This paper was the most cited paper in the knowledge environment of Signalling for that year and currently has 46 citations. Jeremy trained in Dario Alessi's lab, as a postdoc from November 2006 - April 2010.
Jeremy stated 'This work was enabled by an environment of discovery at the MRCPPU, in a laboratory focused on disease signaling. All of the authors involved were able to make an impact in the LRRK2 field as is evidenced by this acknowledgement. In fact, detection of phosphorylation at Serines 910 and 935 as a measure of LRRK2 inhibition LRRK2 has enabled many drug discovery programs to continue and are windows into LRRK2 biology.'